Article Text
Abstract
Measures to reduce the spread of COVID-19 have been associated with reduction in other respiratory infections. Results of a national Swedish cohort study of infant pertussis during April 2020–September 2021 were compared with those during January 2014–March 2020. The number of pertussis cases decreased significantly during the COVID-19 pandemic, from an average of 21 infant cases per quarter of a year before the pandemic to an average of 1 case per quarter during the pandemic. Swedish strategies to mitigate the spread of COVID-19 seem to have had an impact on pertussis incidence in infants.
- COVID-19
- epidemiology
- infectious disease medicine
- paediatrics
- child health
Data availability statement
Data are available in a public, open access repository.
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usageStatistics from Altmetric.com
Data availability statement
Data are available in a public, open access repository.
Footnotes
Contributors KF-H took the lead in writing the manuscript and coordinated the project. EA contributed to data analysis and manuscript revisions. HK performed the data analysis. A-SFC, LJN and S-AS contributed to analysis of the results and to writing of the manuscript. JS contributed to design of the research report, data control and manuscript revisions. BA conceived of the presented report and directed the project. All authors discussed the results and contributed to the final manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests JS reports having been a member of the safety monitoring committee organised by ILIAD, USA in 'A phase 2b multicenter placebo-controlled – randomized study of 3P2EI intranasal pertussis vaccine in healthy adults' in 2020. He did not receive payment.
Provenance and peer review Not commissioned; externally peer reviewed.